Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial-Reference-Cited by-同舟云学术

Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial

Published:2018-03-28 Issue:7 Volume:73 Page:1965-1971
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Blanco Jose L¹,Rojas Jhon¹,Paredes Roger²,Negredo Eugenia²,Mallolas Josep¹,Casadella Maria²,Clotet Bonaventura²,Gatell Jose M¹,de Lazzari Elisa¹,Martinez Esteban¹,Inciarte Alexy,Laguno Montserrat,Martinez-Rebollar Maria,Torres Berta,Lonca Montserrat,Tricas Amparo,Rodriguez Ana,Callau Pilar,Plana Montserrat,Crespo Alberto,Sanchez Sonsoles,Carne Xavier,Martinez Jose A,Vidal Francesc,

Affiliation:

1. Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain

2. Hospital Universitari Germans Trias i Pujol, Badalona, Spain

Funder

Instituto de Salud Carlos III

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/73/7/1965/26151208/dky093.pdf

Reference15 articles.